ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2021, '557 Assessment of skin of color and diversity and inclusion content published in the Journal of Investigative Dermatology: An analysis and call to action', Journal of Investigative Dermatology, 141, pp. S97 - S97, http://dx.doi.org/10.1016/j.jid.2021.02.584
,2021, '615 Efficacy and safety of Oleogel-S10 (birch triterpenes) for recessive dystrophic epidermolysis bullosa (RDEB): Results of 3 months double-blind treatment of the phase 3 study ‘EASE’', Journal of Investigative Dermatology, 141, pp. S107 - S107, http://dx.doi.org/10.1016/j.jid.2021.02.644
,2021, 'A dark lesion on an Indian Woman's vulva', International Journal of Women's Dermatology, 7, pp. 201 - 202, http://dx.doi.org/10.1016/j.ijwd.2021.02.004
,2021, 'Efficacité et innocuité de l’Oleogel-S10 (triterpènes de bouleau) dans l’épidermolyse bulleuse : résultats à 3 mois de l’étude de phase 3 « EASE » en double aveugle', Annales de Dermatologie et de Vénéréologie - FMC, 1, pp. A107 - A107, http://dx.doi.org/10.1016/j.fander.2021.09.525
,2021, 'Introduction and purpose: The House of Medicine & Dermatology.', Int J Womens Dermatol, 7, pp. 517 - 518, http://dx.doi.org/10.1016/j.ijwd.2021.09.005
,2020, 'Osteoporosis and bone health in autoimmune blistering skin disease—an evidenced based review', Journal of the European Academy of Dermatology and Venereology, 34, pp. 2745 - 2756, http://dx.doi.org/10.1111/jdv.16334
,2020, 'International collaboration', Journal of Dermatological Treatment, 31, pp. 757, http://dx.doi.org/10.1080/09546634.2020.1794290
,2020, 'A giant in dermatology has fallen: Robert Alan "Al'' Briggaman, MD IN MEMORY', JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 83, pp. E381 - E381, http://dx.doi.org/10.1016/j.jaad.2020.06.076
,2020, 'COVID-19 and immunosuppressive therapy in dermatology', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.14140
,2020, 'Dermatology and specialty rotations: COVID-19 may reemphasize the importance of internal medicine', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13996
,2020, 'Financial burden of epidermolysis bullosa on patients in the United States', Pediatric Dermatology, 37, pp. 1198 - 1201, http://dx.doi.org/10.1111/pde.14340
,2020, 'Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology', Journal of the American Academy of Dermatology, 83, pp. 1315 - 1322, http://dx.doi.org/10.1016/j.jaad.2020.01.049
,2020, 'Role of music therapy in reducing the burden of dermatological diseases during COVID-19', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.14086
,2020, 'Sensitivity to change and correlation between the autoimmune bullous disease quality-of-life questionnaires ABQOL and TABQOL, and objective severity scores', British Journal of Dermatology, 183, pp. 944 - 945, http://dx.doi.org/10.1111/bjd.19173
,2020, 'Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13956
,2020, 'Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility', British Journal of Dermatology, 183, pp. 614 - 627, http://dx.doi.org/10.1111/bjd.18921
,2020, 'Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts', Journal of the American Academy of Dermatology, 83, pp. 1222 - 1224, http://dx.doi.org/10.1016/j.jaad.2020.06.1023
,2020, 'Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus', Veterinary Dermatology, 31, pp. 410 - e110, http://dx.doi.org/10.1111/vde.12878
,2020, 'Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris', International Journal of Women's Dermatology, 6, pp. 306 - 310, http://dx.doi.org/10.1016/j.ijwd.2020.03.043
,2020, 'Outcomes and Predictors for Re-stenosis of Esophageal Stricture in Epidermolysis Bullosa: A Multicenter Cohort Study', Journal of Pediatric Gastroenterology and Nutrition, 71, pp. 310 - 314, http://dx.doi.org/10.1097/MPG.0000000000002820
,2020, 'Splicing of the cake can affect the severity of epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 34, pp. 1879 - 1880, http://dx.doi.org/10.1111/jdv.16859
,2020, 'Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)', Journal of the European Academy of Dermatology and Venereology, 34, pp. 1900 - 1913, http://dx.doi.org/10.1111/jdv.16752
,2020, 'Use of face masks in dermatology department during the COVID-19 outbreak', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13521
,2020, 'A systematic review of drug-associated bullous pemphigoid', Acta Dermato-Venereologica, 100, pp. 1 - 9, http://dx.doi.org/10.2340/00015555-3457
,2020, 'Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus', Veterinary Dermatology, 31, pp. 291 - e71, http://dx.doi.org/10.1111/vde.12841
,2020, 'Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-020-01435-3
,2020, 'A dermatologist's perspective of the COVID-19 outbreak', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13538
,2020, 'Atypical Disseminated Variant of Galli-Galli Disease: A Review of the Literature', American Journal of Dermatopathology, 42, pp. 484 - 490, http://dx.doi.org/10.1097/DAD.0000000000001467
,2020, 'Restructuring an academic dermatology practice during the COVID-19 pandemic', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13684
,2020, 'Successful dapsone therapy in inherited epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 34, pp. e333 - e334, http://dx.doi.org/10.1111/jdv.16301
,2020, 'Update on COVID-19 effects in dermatology specialty', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13523
,2020, 'Virtual conferences of dermatology during the COVID-19 pandemic', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13774
,2020, 'Where do we stand as dermatologists in combat with COVID-19', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13638
,2020, 'Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: A phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-020-01419-3
,2020, 'A prickly souvenir from a hedgehog café: tinea manuum secondary to Trichophyton erinacei via international spread', Clinical and Experimental Dermatology, 45, pp. 459 - 461, http://dx.doi.org/10.1111/ced.14111
,2020, 'Biologics and Small Molecules in the Treatment of COVID-19', Journal of drugs in dermatology : JDD, 19, pp. 673 - 675
,2020, 'Multiple milia formation in blistering diseases', International Journal of Women's Dermatology, 6, pp. 199 - 202, http://dx.doi.org/10.1016/j.ijwd.2020.03.045
,2020, 'Reply to: “Biologics for psoriasis during COVID-19 outbreak”', Journal of the American Academy of Dermatology, 82, pp. e219, http://dx.doi.org/10.1016/j.jaad.2020.04.014
,2020, 'Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”', Journal of the American Academy of Dermatology, 82, pp. e215, http://dx.doi.org/10.1016/j.jaad.2020.03.103
,2020, 'The Potential Protective Effect of Estrogen: Why is COVID-19 mortality lower in females than males', International Journal of Women's Dermatology, 6, pp. 152 - 153, http://dx.doi.org/10.1016/j.ijwd.2020.04.011
,2020, 'The response of the Women's Dermatologic Society and the International Journal of Women's Dermatology to the COVID-19 pandemic', International Journal of Women's Dermatology, 6, pp. 129 - 130, http://dx.doi.org/10.1016/j.ijwd.2020.04.008
,2020, 'Treatment considerations for patients with pemphigus during the COVID-19 pandemic', Journal of the American Academy of Dermatology, 82, pp. e235 - e236, http://dx.doi.org/10.1016/j.jaad.2020.04.005
,2020, 'Drug-related adverse effects of vismodegib and sonidegib for locally advanced or metastatic basal cell carcinoma', Australasian Journal of Dermatology, 61, pp. 176 - 177, http://dx.doi.org/10.1111/ajd.13205
,2020, 'Should biologics for psoriasis be interrupted in the era of COVID-19?', Journal of the American Academy of Dermatology, 82, pp. 1217 - 1218, http://dx.doi.org/10.1016/j.jaad.2020.03.031
,2020, 'Diagnosis and management of pemphigus: Recommendations of an international panel of experts', Journal of the American Academy of Dermatology, 82, pp. 575 - 585.e1, http://dx.doi.org/10.1016/j.jaad.2018.02.021
,2020, 'Novel diagnostic method to differentiate antilaminin-332 pemphigoid from other forms of pemphigoid', British Journal of Dermatology, 182, pp. 270 - 271, http://dx.doi.org/10.1111/bjd.18372
,2020, 'The challenges of living with and managing epidermolysis bullosa: Insights from patients and caregivers', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-019-1279-y
,2020, 'Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus', Journal of Allergy and Clinical Immunology, 145, pp. 173 - 182, http://dx.doi.org/10.1016/j.jaci.2019.08.013
,2020, 'Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus', Journal of the European Academy of Dermatology and Venereology, 34, pp. 153 - 160, http://dx.doi.org/10.1111/jdv.15770
,2020, '12871 A systematic review of drug-induced pemphigoid', Journal of the American Academy of Dermatology, 83, pp. AB113 - AB113, http://dx.doi.org/10.1016/j.jaad.2020.06.539
,